13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoic acid

Term ID

CHEBI:140257

Synonyms

(7Z,9E,11E,14S,16Z,19Z)-13,14-dihydroxydocosa-7,9,11,16,19-pentaenoic acid
(7Z,9E,11E,14S,16Z,19Z)-13,14-dihydroxydocosapentaenoic acid
13,14(S)-dihydroxy-omega3-docosapentaenoic acid
MaR2n-3 DPA

Definition

A docosanoid that is (7Z,9E,11E,16Z,19Z)-docosapentaenoic acid carrying two hydroxy substituents at positions 13 and 14. An intermediate of specialised proresolving mediators.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: docosanoid hydroxy polyunsaturated fatty acid long-chain fatty acid secondary allylic alcohol

docosanoid hydroxy polyunsaturated fatty acid long-chain fatty acid secondary allylic alcohol Show first 5 Terms
has_role: anti-inflammatory agent human xenobiotic metabolite

anti-inflammatory agent human xenobiotic metabolite Show first 5 Terms
inverse is_conjugate_base_of: 13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate

13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate Show first 5 Terms
is_conjugate_acid_of: 13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate

13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate Show first 5 Terms

Phenotype

Phenotype resulting from 13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoic acid

Phenotype where environments contain 13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoic acid

Phenotype modified by environments containing 13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoic acid

Human Disease Model